Active Biotech AB, a Swedish biotech company with five drug projects under clinical development, has announced details of its SEK 256 million (€23.8 million) rights issue scheduled for completion on 10 June 2009. ---Subscribe to MedNous to access this article--- Finance, Grants, Deals
